Enhanced antisense inhibition of human immunodeficiency virus type 1 in cell cultures by DLS delivery system

Biochemical and Biophysical Research Communications

Volumn 237, Issue 3, 1997, Pages 566-571

  Lavigne, Carole ^a   Thierry, Alain R ^b  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b Biovector Therapeutics   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; LIPOSOME; OLIGODEOXYNUCLEOTIDE PHOSPHOROTHIOATE;

ANTIVIRAL ACTIVITY; ARTICLE; CELL CULTURE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; PRIORITY JOURNAL; VIRUS INHIBITION;

EID: 0031589547     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1006/bbrc.1997.7191     Document Type: Article

References (29)

1. Eckstein F. Science Spectra. 7:1996;56-61.
2. Agrawal S., Sarin P. S., Zamecnik M., Zamecnik P. C. Gene Regulation: Biology of Antisense RNA and DNA. 1992;Raven Press, New York. p. 273-283.
3. Stein C. A., Cheng Y.-C. Science. 261:1993;1004-1012.
4. Thierry A. R., Takle G. B. Akhtar S. Delivery Strategies for Antisense Oligonucleotide Therapeutics. 1995;199-221 CRC Press, Boca Raton.
5. Rojanasakul Y. Advanced Drug Delivery Reviews. 18:1996;115-131.
6. Thierry A. R., Rahman A., Dritschilo A. Erickson R. P., Izant J. G. Gene Regulation: Antisense RNA and DNA. 1992;147-161 Raven Press, New York.
7. Thierry A. R., Dritschilo A. Ann. N.Y. Acad. Sci. 660:1992;300-302.
8. Thierry A. R., Dritschilo A. Nucleic Acids Res. 20:1992;5691-5698.
9. Thierry A. R., Rahman A., Dritschilo A. Biochem. Biophys. Res. Commun. 190:1993;952-960.
10. Bennett C. F., Chiang M.-Y., Chan H. C., Shoemaker J. E. E., Mirabelli C. K. Mol. Pharmacol. 41:1992;1023-1033.
11. Bennett C. F., Chiang M.-Y., Chan H., Grimm S. J. Liposome Res. 3:1993;85-102.
12. Wagner R. W. Nature. 372:1994;333-335.
13. Anazodo M. I., Wainberg M. A., Friesen A. D., Wright J. A. J. Virol. 69:1995;1794-1801.
14. Hatta T., Nakagawa Y., Takai K., Nakada S., Yokota T., Takaku H. Biochem. Biophys. Res. Commun. 223:1996;341-346.
15. Ropert C., Lavignon M., Dubernet C., Couvreur P., Malvy C. Biochem. Biophys. Res. Commun. 183:1992;879-885.
16. Leonetti J.-P., Machy P., Degols G., Lebleu B., Leserman L. Proc. Natl. Acad. Sci. USA. 87:1990;2448-2451.
17. Leserman L., Machy P., Zelphati O. J. Liposome Res. 4:1994;107-119.
18. Zelphati O., Imbach J.-L., Signoret N., Zon G., Rayner B., Leserman L. Nucleic Acids Res. 22:1994;4307-4314.
19. Selvam M. P., Buck S. M., Blay R. A., Mayner R. E., Mied P. A., Epstein J. S. Antivir. Res. 33:1996;11-20.
20. Thierry A. R., Lunardi-Iskandar Y., Bryant J. L., Rabinovich P., Gallo R. C., Mahan L. C. Proc. Natl. Acad. Sci. USA. 92:1995;9742-9746.
21. Thierry A. R., Rabinovich P., Peng B., Mahan L. C., Bryant J. L., Gallo R. C. Gene Ther. 4:1997;226-237.
22. Matsukura M., Zon G., Shinozuka K., Robert-Guroff M., Shimada T., Stein C. A., Mitsuya H., Wong-Staal F., Cohen J. S., Broder S. Proc. Natl. Acad. Sci. USA. 86:1989;4244-4248.
23. Popovic M., Read-Conole E., Gallo R. C. Lancet. II:1984;1472-1473.
24. Popovic M., Sarngadharan M. G., Read E., Gallo R. C. Science. 224:1984;497-500.
25. Pauwels R., Balzarini J., Baba M., Snoeck R., Schols D., Herdewijn P., Desmyter J., De Clercq E. J. Virol. Methods. 20:1988;309-321.
26. Felgner P. L., Barenholz Y., Behr J. P., Cheng S. H., Cullis P., Huang L., Jessee J. A., Seymour L., Szoka F., Thierry A. R., Wagner E., Wu G. Hum. Gene Ther. 8:1997;511-512.
27. Stein C. A., Tonkinson J. L., Yakubov L. Pharmacol. Ther. 52:1991;365-384.
28. Akhtar S., Kole R., Juliano R. L. Life Sci. 49:1991;1793-1801.
29. Crooke S. T. Annu. Rev. Pharmacol. Toxicol. 32:1992;329-376.